Clinical Trials Directory

Trials / Conditions / Stage IVA Oral Cavity Squamous Cell Carcinoma

Stage IVA Oral Cavity Squamous Cell Carcinoma

8 registered clinical trials studyying Stage IVA Oral Cavity Squamous Cell Carcinoma.

StatusTrialSponsorPhase
CompletedNivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carc
NCT03342911
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 2
TerminatedDurvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
NCT02827838
Wake Forest University Health SciencesEARLY_Phase 1
TerminatedStereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
NCT02388932
Case Comprehensive Cancer CenterN/A
TerminatedGanetespib Window of Opportunity Study in Head and Neck Cancers
NCT02334319
Emory UniversityPhase 1
CompletedSorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell C
NCT02035527
Ohio State University Comprehensive Cancer CenterPhase 1
TerminatedCapecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT01267240
National Cancer Institute (NCI)Phase 2
CompletedTPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma
NCT01542931
Shanghai Jiao Tong University School of MedicinePhase 2 / Phase 3
CompletedPhase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
NCT01469429
Ohio State University Comprehensive Cancer CenterPhase 1 / Phase 2